Printer Friendly
The Free Library
23,403,340 articles and books


MDL, Derwent, and ISI Agree to Provide Integrated Discovery Knowledge Through DiscoveryGate.

Business Editors/Health & Medical Writers

BOSTON--(BW HealthWire)--Aug. 19, 2002

Agreement Gives Researchers Easy Access to Integrated Patent and

Chemical Information from World's Leading Authorities

MDL Information Systems, Inc. (MDL(R)), Derwent Information, and ISI(R) announced that they are collaborating to index chemical structures in selected Derwent and ISI patent and chemical information databases into DiscoveryGate(SM) -- MDL's Web-based service that integrates, indexes, and links the essential content sources required for effective drug discovery. The first phase of this new, expanded scientific information resource will be available to researchers during 2002.

"This critical link between DiscoveryGate and selected Derwent and ISI databases will streamline scientific inquiry and accelerate the discovery process," said MDL president and CEO Pat Rougeau. "Customer feedback indicated that access to current patent information is crucial to researchers. This important collaboration makes DiscoveryGate the complete knowledge navigation solution for chemistry and life science researchers around the world -- and the first place to go for the answers to discovery questions."

Indexing and linking Derwent and ISI databases in DiscoveryGate means that researchers can perform single-query searches within DiscoveryGate to explore published information on particular compounds, including available patent listings, and then link to Derwent Discovery(TM) or to Derwent or ISI databases available in-house under MDL(R) ISIS for details. Derwent and ISI sources in DiscoveryGate include:
-- CrossFire Beilstein

-- MDL(R) Available Chemicals Directory

-- ChemInform Reaction Library

-- MDL(R) Drug Data Report

-- MDL(R) Metabolite Database

-- MDL(R) Toxicity Database

-- MDL(R) Screening Compounds Directory

-- MDL(R) Solid-Phase Organic Reactions

-- MDL(R) Comprehensive Medicinal Chemistry

-- Current Synthetic Methodology

-- MDL(R) Comprehensive Heterocyclic Chemistry

-- MDL(R) ORGSYN Database

-- MDL(R) Reference Library of Synthetic Methodology

-- National Cancer Institute Database

-- AIDS Database


"The world's top companies depend on Derwent's scientific and patent information to stay on top of the latest developments in today's fast moving markets," said Mike Tansey, president and CEO of Thomson Scientific. "Making selected Derwent and ISI databases available through DiscoveryGate is an effective way to get critical information to researchers' desktops in an accessible, easy-to-use, Web-based environment."

When researchers locate compounds in a Derwent or ISI database, they can link to DiscoveryGate to explore the physical properties of the compounds, pertinent metabolism or toxicology studies, preparations to make the compounds, and commercial suppliers. MDL's DiscoveryGate indexes more than 11 million structures and provides easy links to access associated reactions and over 200 million facts from the following databases:


-- CrossFire Beilstein

-- MDL(R) Available Chemicals Directory

-- ChemInform Reaction Library

-- MDL(R) Drug Data Report

-- MDL(R) Metabolite Database

-- MDL(R) Toxicity Database

-- MDL(R) Screening Compounds Directory

-- MDL(R) Solid-Phase Organic Reactions

-- MDL(R) Comprehensive Medicinal Chemistry

-- Current Synthetic Methodology

-- MDL(R) Comprehensive Heterocyclic Chemistry

-- MDL(R) ORGSYN Database

-- MDL(R) Reference Library of Synthetic Methodology

-- National Cancer Institute Database

-- AIDS Database



About Derwent Information Limited

Derwent Information is the world's leading patent and scientific information provider. Derwent helps top life science and chemical companies stay ahead of their competitors by providing them with key technical, scientific, and business information drawn from patents, research journals, and conference proceedings. Derwent products, including the unrivalled Derwent Discovery(TM), Derwent GENESEQ(TM) and Derwent World Patents Index(R), are invaluable for monitoring competitor activity, saving R&D resources, keeping up-to-date with trends, generating new revenue sources, and managing patent portfolios. Derwent is part of The Thomson Corporation. For more information about Derwent, visit www.derwent.co.uk.

About ISI

Headquartered in Philadelphia, Pa., U.S. with offices worldwide, ISI provides essential, high quality Web-based information to over seven million researchers, information specialists, and administrators in diverse fields. ISI is part of The Thomson Corporation. For more information about ISI, visit www.isinet.com.

About The Thomson Corporation

The Thomson Corporation, with 2001 revenues of $7.2 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software applications and tools to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare. The Corporation's common shares are listed on the New York and Toronto Stock Exchanges (NYSE: TOC; TSX: TOC). For more information about The Thomson Corporation, visit www.thomson.com.

About MDL

Over 1,000 life science companies supercharge their discovery engines with MDL software solutions to generate fresh ideas and make breakthrough discoveries. By synchronizing and streamlining the sharing and management of vital information and knowledge, we enable scientists to work more efficiently and invent drugs faster. This saves time, money, and lives. In support of our customers and the momentous challenges they face, everything we do must be reliable, resourceful, innovative, and insightful. We are an international business headquartered in San Leandro, Calif., with offices worldwide. MDL is a wholly owned subsidiary of Elsevier Science, Inc., which is part of the Reed Elsevier Group plc, owned by Reed Elsevier PLC (NYSE: RUK) and Reed Elsevier NV (NYSE: ENL). For more information, visit www.mdl.com.

Note to Editors: MDL and LitLink are registered trademarks in the United States; "Powering the Process of Invention" is a trademark and DiscoveryGate is a service mark of MDL Information Systems, Inc., U.S. registration pending. CrossFire is Copyright (c) 1995-2002, and a registered trademark of MDL Information Systems GmbH. Beilstein Database is Copyright (c) 1988-2002, Beilstein-Institut zur Forderung der Chemischen Wissenschaften licensed to Beilstein Chemiedaten und Software GmbH and MDL Information Systems GmbH, used herein under permission. Derwent and Derwent World Patents Index are registered trademarks of Derwent Information Limited. ISI, Current Chemical Reactions, CCR, and Index Chemicus are registered trademarks of ISI. Thomson is a registered trademark and trademark of the Thomson Corporation and its affiliated companies. All other company and/or product names may be trademarks or registered trademarks of their respective owners in the United States and other countries. All rights reserved.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:MDL, Derwent, and ISI Agree to Provide Integrated Discovery Knowledge Through DiscoveryGate.
Publication:Business Wire
Geographic Code:1CANA
Date:Aug 19, 2002
Words:980
Previous Article:Mentor Graphics Offers Free Training to Displaced Engineers.
Next Article:Dr. Mickey S. Urdea Appointed to the Board of Directors of Quantum Dot Corporation.
Topics:



Related Articles
To join an MDL ... or not.
Smartlogik to Provide Thomson ISI With Cross-Database Discovery and Structure Solutions.
Current Drugs Ltd. sold to Thomson Corp.
MDL and Current Drugs Collaborate to Index Investigational Drugs Database -- IDdb -- into DiscoveryGate.
Derwent Innovations Index Enhanced With Expanded Chemistry Content and Search Functionality.
Thomson ISI Sponsors Workshops for the United Kingdom Higher Education Community; CHEST Consortia First to Upgrade to ISI Web of Knowledge Intranet...
Thomson ISI Sponsors Workshops for the United Kingdom Higher Education Community; CHEST Consortia First to Upgrade to ISI Web of Knowledge Intranet...
Thomson ISI Sponsors Workshops for the United Kingdom Higher Education Community; CHEST Consortia First to Upgrade to ISI Web of Knowledge Intranet...
Thomson Corp. acquires Newport Strategies, Inc. & CGI Division.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters